Electrocore To Participate In The Canaccord Genuity Medtech, Diagnostics And Digital Health & Services Forum
Joshua Lev, Co-Chief Executive Officer, President and Chief Financial Officer, will present at the conference and host one-on-one meetings with investors throughout the day.
Investors interested in scheduling a one-on-one meeting should contact their Canaccord Genuity sales representative.
About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company's two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use TruvagaTM and TAC-STIMTM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit .
Contact:
ECOR Investor Relations
(973) 302-9253
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment